Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Cigna GroupWBO:CIGN -1.24%66 EV-to-EBIT is 10.79 as of Jul. 15, 2026, which is 49% below its 10-year median of 21.00. GuruFocus rates WBO:CIGN with a GF Score™ of 66/100 and a GF Value™ of €369.84 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 14 Healthcare Plans companies, The Cigna Group ranks better than 71.43% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
The Cigna Group's Enterprise Value for the quarter that ended in Mar. 2026 was €80,250 Mil.
The Cigna Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €8,429 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cigna Group EV-to-EBIT Related Terms
The Cigna Group EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for The Cigna Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, The Cigna Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cigna Group EV-to-EBIT vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, The Cigna Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where The Cigna Group's EV-to-EBIT falls into.
The Cigna Group's current Enterprise Value is €90,953 Mil.
The Cigna Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €8,429 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cigna Group (WBO:CIGN) has a EV-to-EBIT of 10.79 as of Jul. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on The Cigna Group and its competitors. This is 49% below median its historical median of 21.00. Over the past decade, The Cigna Group's EV-to-EBIT has ranged from 5.14 to 761.27. According to the industry distribution chart, The Cigna Group ranks #4 out of 14 companies in the Healthcare Plans industry, placing it in the top 28.6%.
Is The Cigna Group's EV-to-EBIT too high?
The Cigna Group's current EV-to-EBIT of 10.79 is 49% below median its 10-year median of 21.00. Over the past 10 years, this metric has ranged from a low of 5.14 to a high of 761.27. The Healthcare Plans industry median EV-to-EBIT is 20.34. The Cigna Group's value of 10.79 is 46.9% below this industry median. Based on the distribution chart, The Cigna Group ranks #4 out of 14 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, The Cigna Group has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's EV-to-EBIT compare to ELV and HUM?
According to the Healthcare Plans industry distribution chart, The Cigna Group ranks #4 out of 14 companies for EV-to-EBIT. This puts The Cigna Group in the upper half of its industry. The industry median EV-to-EBIT is 20.34. The Cigna Group's value of 10.79 is 46.9% below this benchmark. Historically, The Cigna Group's own EV-to-EBIT has ranged from 5.14 to 761.27 over the past decade. While the company's 10-year median is 21.00 vs. the industry median of 20.34, The Cigna Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Plans company?
The median EV-to-EBIT among Healthcare Plans companies is 20.34, based on 14 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cigna Group's current EV-to-EBIT of 10.79 is 46.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on The Cigna Group and its competitors. For the Healthcare Plans industry, the median EV-to-EBIT is 20.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cigna Group's current EV-to-EBIT is 10.79, which is 49% below median its own 10-year median of 21.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (WBO:CIGN) is currently considered Modestly Undervalued. The stock's GF Value™ is €369.84, compared to a current price of €262.10 — trading 29.1% below its estimated fair value. The current EV-to-EBIT is 10.79, which is 49% below median its 10-year median of 21.00 and 46.9% below the Healthcare Plans industry median of 20.34. The Cigna Group's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For The Cigna Group (WBO:CIGN), the current EV-to-EBIT is 10.79 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cigna Group (WBO:CIGN) Overvalued in 2026?
Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued.
The current stock price of €262.10 is trading 29.1% below its estimated GF Value™ of €369.84.
GuruFocus considers The Cigna Group to be Modestly Undervalued.
Key valuation signals for WBO:CIGN:
EV-to-EBIT: 10.79 (49% below median its 10-year median of 21.00)
GF Value™: €369.84 vs. price of €262.10 (29.1% below fair value)
Industry Position: 46.9% below the Healthcare Plans median (#4 of 14)
No single metric tells the full story. See the WBO:CIGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
66GF Score
Get the complete analysis for WBO:CIGN
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:CIGN has been successfully added to your 
